Fatty Liver and GLP-1s

by | Jul 26, 2026 | Blog

The 05/27/2026 article “GLP-1s Gain Traction for Treating Fatty Liver Disease” central message is that GLP-1 receptor agonists (particularly semaglutide/Wegovy and tirzepatide) are rapidly moving from “weight-loss drugs” to becoming mainstream...

Incidental Finding in Imaging: Liver

by | Jul 24, 2026 | Blog

July 23, 2026: Medscape In Discussion: MASLD.This video speaks to when fatty liver appears incidentally on imaging, “just lose weight” isn’t enough. Dr. Danielle Brandman of Weill Cornell Medicine explains how to use FIB-4, FibroScan, and ELF to...

MASLD Treatment: New Era

by | Jun 29, 2026 | Blog

Here are the key takeaways from the HCPLive article, “Lifestyle, Pharmacologic Therapies, and EXCEL Trial Data Reshape MASLD Treatment Framework,” by Dr. Zobair Younossi (published June 23, 2026). 1. MASLD treatment is entering a new era The article argues...